vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Industrial Logistics Properties Trust (ILPT). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $113.9M, roughly 1.7× Industrial Logistics Properties Trust). Industrial Logistics Properties Trust runs the higher net margin — -1.6% vs -14.6%, a 13.0% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 3.1%). Industrial Logistics Properties Trust produced more free cash flow last quarter ($42.0M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 0.7%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.
AXSM vs ILPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $113.9M |
| Net Profit | $-28.6M | $-1.8M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | -22.1% |
| Net Margin | -14.6% | -1.6% |
| Revenue YoY | 65.0% | 3.1% |
| Net Profit YoY | 61.9% | 92.6% |
| EPS (diluted) | $-0.55 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $113.9M | ||
| Q3 25 | $171.0M | $110.9M | ||
| Q2 25 | $150.0M | $112.1M | ||
| Q1 25 | $121.5M | $111.9M | ||
| Q4 24 | $118.8M | $110.5M | ||
| Q3 24 | $104.8M | $108.9M | ||
| Q2 24 | $87.2M | $110.6M | ||
| Q1 24 | $75.0M | $112.2M |
| Q4 25 | $-28.6M | $-1.8M | ||
| Q3 25 | $-47.2M | $-21.6M | ||
| Q2 25 | $-48.0M | $-21.3M | ||
| Q1 25 | $-59.4M | $-21.5M | ||
| Q4 24 | $-74.9M | $-24.1M | ||
| Q3 24 | $-64.6M | $-25.0M | ||
| Q2 24 | $-79.3M | $-23.2M | ||
| Q1 24 | $-68.4M | $-23.4M |
| Q4 25 | -13.8% | -22.1% | ||
| Q3 25 | -27.0% | -29.4% | ||
| Q2 25 | -24.5% | -30.8% | ||
| Q1 25 | -46.9% | -26.9% | ||
| Q4 24 | -61.1% | -31.1% | ||
| Q3 24 | -59.8% | -33.5% | ||
| Q2 24 | -89.5% | -32.4% | ||
| Q1 24 | -89.7% | -31.7% |
| Q4 25 | -14.6% | -1.6% | ||
| Q3 25 | -27.6% | -19.4% | ||
| Q2 25 | -32.0% | -19.0% | ||
| Q1 25 | -48.9% | -19.2% | ||
| Q4 24 | -63.1% | -21.8% | ||
| Q3 24 | -61.7% | -22.9% | ||
| Q2 24 | -91.0% | -20.9% | ||
| Q1 24 | -91.1% | -20.9% |
| Q4 25 | $-0.55 | $-0.02 | ||
| Q3 25 | $-0.94 | $-0.33 | ||
| Q2 25 | $-0.97 | $-0.32 | ||
| Q1 25 | $-1.22 | $-0.33 | ||
| Q4 24 | $-1.54 | $-0.37 | ||
| Q3 24 | $-1.34 | $-0.38 | ||
| Q2 24 | $-1.67 | $-0.35 | ||
| Q1 24 | $-1.44 | $-0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $94.8M |
| Total DebtLower is stronger | — | $4.2B |
| Stockholders' EquityBook value | $88.3M | $489.7M |
| Total Assets | $689.8M | $5.2B |
| Debt / EquityLower = less leverage | — | 8.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $94.8M | ||
| Q3 25 | $325.3M | $83.2M | ||
| Q2 25 | $303.0M | $58.6M | ||
| Q1 25 | $300.9M | $108.0M | ||
| Q4 24 | $315.4M | $131.7M | ||
| Q3 24 | $327.3M | $153.9M | ||
| Q2 24 | $315.7M | $146.2M | ||
| Q1 24 | $331.4M | $128.4M |
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | $4.2B | ||
| Q2 25 | — | $4.2B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.3B | ||
| Q1 24 | — | $4.3B |
| Q4 25 | $88.3M | $489.7M | ||
| Q3 25 | $73.7M | $494.1M | ||
| Q2 25 | $73.1M | $519.1M | ||
| Q1 25 | $53.2M | $539.5M | ||
| Q4 24 | $57.0M | $562.0M | ||
| Q3 24 | $92.9M | $585.9M | ||
| Q2 24 | $102.9M | $618.3M | ||
| Q1 24 | $144.0M | $643.2M |
| Q4 25 | $689.8M | $5.2B | ||
| Q3 25 | $669.3M | $5.2B | ||
| Q2 25 | $639.8M | $5.2B | ||
| Q1 25 | $596.7M | $5.4B | ||
| Q4 24 | $568.5M | $5.4B | ||
| Q3 24 | $561.5M | $5.5B | ||
| Q2 24 | $548.2M | $5.5B | ||
| Q1 24 | $545.7M | $5.5B |
| Q4 25 | — | 8.56× | ||
| Q3 25 | — | 8.49× | ||
| Q2 25 | — | 8.09× | ||
| Q1 25 | — | 7.96× | ||
| Q4 24 | — | 7.65× | ||
| Q3 24 | — | 7.35× | ||
| Q2 24 | — | 6.96× | ||
| Q1 24 | — | 6.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $60.7M |
| Free Cash FlowOCF − Capex | $-18.7M | $42.0M |
| FCF MarginFCF / Revenue | -9.6% | 36.9% |
| Capex IntensityCapex / Revenue | 0.0% | 16.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $79.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $60.7M | ||
| Q3 25 | $1.0M | $22.7M | ||
| Q2 25 | $-32.4M | $18.4M | ||
| Q1 25 | $-43.4M | $11.4M | ||
| Q4 24 | $-26.2M | $2.0M | ||
| Q3 24 | $-18.6M | $-3.4M | ||
| Q2 24 | $-30.1M | $10.8M | ||
| Q1 24 | $-53.5M | $8.0M |
| Q4 25 | $-18.7M | $42.0M | ||
| Q3 25 | $988.0K | $17.6M | ||
| Q2 25 | $-32.4M | $15.2M | ||
| Q1 25 | $-43.7M | $5.0M | ||
| Q4 24 | $-26.2M | $-3.7M | ||
| Q3 24 | $-18.7M | $-5.9M | ||
| Q2 24 | $-30.2M | $9.4M | ||
| Q1 24 | $-53.6M | $5.9M |
| Q4 25 | -9.6% | 36.9% | ||
| Q3 25 | 0.6% | 15.9% | ||
| Q2 25 | -21.6% | 13.5% | ||
| Q1 25 | -36.0% | 4.5% | ||
| Q4 24 | -22.1% | -3.4% | ||
| Q3 24 | -17.9% | -5.5% | ||
| Q2 24 | -34.6% | 8.5% | ||
| Q1 24 | -71.4% | 5.2% |
| Q4 25 | 0.0% | 16.4% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 0.0% | 2.9% | ||
| Q1 25 | 0.3% | 5.7% | ||
| Q4 24 | 0.0% | 5.2% | ||
| Q3 24 | 0.1% | 2.3% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.1% | 1.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
